Jane Street Group LLC purchased a new stake in Abrdn Healthcare Investors (NYSE:HQH - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 17,790 shares of the financial services provider's stock, valued at approximately $286,000.
Several other hedge funds have also recently modified their holdings of HQH. Triumph Capital Management grew its position in Abrdn Healthcare Investors by 32.6% during the fourth quarter. Triumph Capital Management now owns 61,217 shares of the financial services provider's stock valued at $983,000 after buying an additional 15,057 shares during the period. Comerica Bank increased its position in shares of Abrdn Healthcare Investors by 17.3% during the 4th quarter. Comerica Bank now owns 7,504 shares of the financial services provider's stock valued at $120,000 after purchasing an additional 1,105 shares during the last quarter. Stifel Financial Corp lifted its stake in shares of Abrdn Healthcare Investors by 38.7% in the 4th quarter. Stifel Financial Corp now owns 13,975 shares of the financial services provider's stock valued at $224,000 after acquiring an additional 3,900 shares during the last quarter. First Trust Advisors LP lifted its position in Abrdn Healthcare Investors by 5.8% in the fourth quarter. First Trust Advisors LP now owns 177,740 shares of the financial services provider's stock valued at $2,853,000 after purchasing an additional 9,819 shares during the last quarter. Finally, Guggenheim Capital LLC grew its holdings in shares of Abrdn Healthcare Investors by 13.2% in the fourth quarter. Guggenheim Capital LLC now owns 36,934 shares of the financial services provider's stock worth $593,000 after purchasing an additional 4,313 shares during the last quarter. Institutional investors own 32.60% of the company's stock.
Abrdn Healthcare Investors Trading Up 1.6%
HQH traded up $0.25 during midday trading on Friday, reaching $15.66. 145,223 shares of the company's stock traded hands, compared to its average volume of 193,175. The firm has a fifty day moving average of $15.41 and a two-hundred day moving average of $16.51. Abrdn Healthcare Investors has a 52 week low of $13.77 and a 52 week high of $19.79.
Abrdn Healthcare Investors Increases Dividend
The business also recently announced a quarterly dividend, which will be paid on Monday, June 30th. Stockholders of record on Thursday, May 22nd will be given a $0.54 dividend. This represents a $2.16 annualized dividend and a dividend yield of 13.79%. This is a boost from Abrdn Healthcare Investors's previous quarterly dividend of $0.50. The ex-dividend date of this dividend is Thursday, May 22nd.
About Abrdn Healthcare Investors
(
Free Report)
Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries.
Further Reading
Before you consider abrdn Healthcare Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and abrdn Healthcare Investors wasn't on the list.
While abrdn Healthcare Investors currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
